Close Menu

NEW YORK – In a document filed with the US Securities and Exchange Commission this week, Quest Diagnostics said that since reporting its first quarter results in April, its base business — which excludes COVID-related testing — has recovered more quickly than it had anticipated, and testing volume is higher in areas in the US where state and local governments are lifting restrictions on business activity.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.